Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Prostate (Late Stage^), 2014-2018

All Races (includes Hispanic), Male, All Ages

Sorted by CI*Rank
State
 sort alphabetically by name ascending
Met Healthy People Objective of ***?
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate descending
CI*Rank⋔
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count descending
Percent of Cases with Late Stage
 sort by percent late descending
US (SEER+NPCR) 1 *** 22.0 (21.9, 22.1) N/A 41,329 20.6
Wisconsin 6 *** 29.5 (28.7, 30.3) 1 (1, 4) 1,066 25.6
Iowa 3 *** 29.2 (28.1, 30.3) 2 (1, 5) 571 26.2
Minnesota 6 *** 28.0 (27.2, 28.9) 3 (1, 7) 924 25.1
Montana 6 *** 27.8 (26.1, 29.7) 4 (1, 11) 202 22.0
Vermont 6 *** 27.2 (25.0, 29.6) 5 (1, 18) 120 29.1
Nebraska 6 *** 26.7 (25.3, 28.1) 6 (3, 14) 298 21.9
Louisiana 3 *** 26.3 (25.4, 27.2) 7 (4, 12) 700 19.6
North Dakota 6 *** 26.2 (24.1, 28.5) 8 (2, 23) 116 22.3
Connecticut 3 *** 26.2 (25.2, 27.1) 9 (4, 14) 581 22.7
Hawaii 3 *** 25.2 (23.7, 26.7) 10 (5, 23) 230 26.9
Illinois 6 *** 25.1 (24.6, 25.6) 11 (7, 16) 1,839 22.5
District of Columbia 6 *** 24.8 (22.3, 27.6) 12 (3, 36) 75 19.1
South Dakota 6 *** 24.7 (22.8, 26.7) 13 (4, 30) 131 20.6
Mississippi 6 *** 24.6 (23.6, 25.7) 14 (7, 23) 424 18.7
New York 3 *** 24.4 (24.0, 24.8) 15 (10, 21) 2,759 19.1
Utah 3 *** 24.3 (23.0, 25.5) 16 (8, 26) 318 21.1
Washington 5 *** 24.2 (23.5, 24.9) 17 (10, 23) 1,011 24.1
Oregon 6 *** 24.0 (23.2, 24.9) 18 (10, 25) 622 25.4
Maine 6 *** 23.8 (22.4, 25.3) 19 (8, 31) 234 25.4
Idaho 3 *** 23.8 (22.4, 25.2) 20 (8, 31) 235 21.8
North Carolina 6 *** 23.4 (22.8, 23.9) 21 (15, 27) 1,369 19.2
New Hampshire 6 *** 23.3 (21.9, 24.9) 22 (10, 34) 212 20.7
Pennsylvania 6 *** 23.0 (22.5, 23.5) 23 (18, 28) 1,911 22.0
Ohio 6 *** 22.7 (22.2, 23.2) 24 (20, 31) 1,649 21.3
Georgia 3 *** 22.6 (22.0, 23.2) 25 (20, 32) 1,195 17.5
Rhode Island 6 *** 22.4 (20.8, 24.1) 26 (11, 41) 146 21.3
Alaska 6 *** 22.3 (20.0, 24.9) 27 (8, 42) 80 24.4
California 3 *** 22.3 (22.0, 22.6) 28 (23, 32) 4,583 24.0
Michigan 5 *** 22.2 (21.7, 22.8) 29 (22, 33) 1,413 20.9
Indiana 6 *** 21.9 (21.3, 22.6) 30 (22, 36) 840 22.7
Delaware 6 *** 21.9 (20.2, 23.7) 31 (14, 42) 133 17.3
Tennessee 6 *** 21.6 (20.9, 22.3) 32 (25, 38) 863 18.9
Missouri 6 *** 21.3 (20.7, 22.0) 33 (27, 39) 795 22.8
Colorado 6 *** 21.3 (20.5, 22.1) 34 (26, 40) 627 22.3
Wyoming 6 *** 21.0 (18.9, 23.3) 35 (15, 45) 79 18.9
New Jersey 3 *** 21.0 (20.4, 21.5) 36 (30, 40) 1,094 15.6
Arkansas 6 *** 20.6 (19.6, 21.5) 37 (29, 42) 373 17.4
Maryland 6 *** 20.6 (19.9, 21.3) 38 (31, 42) 707 16.1
Kentucky 3 *** 20.3 (19.5, 21.1) 39 (32, 42) 533 19.0
South Carolina 6 *** 20.3 (19.5, 21.0) 40 (33, 42) 632 17.9
Texas 6 *** 19.7 (19.4, 20.0) 41 (38, 42) 2,646 20.3
Kansas 6 *** 19.7 (18.7, 20.7) 42 (34, 43) 335 18.0
Virginia 6 *** 18.3 (17.7, 18.9) 43 (42, 46) 875 18.3
Alabama 6 *** 18.1 (17.4, 18.8) 44 (42, 47) 539 15.0
Florida 6 *** 18.0 (17.7, 18.4) 45 (43, 46) 2,573 18.9
New Mexico 3 *** 17.5 (16.5, 18.6) 46 (42, 49) 226 21.2
Oklahoma 6 *** 16.9 (16.2, 17.7) 47 (44, 49) 383 17.8
Arizona 6 *** 16.8 (16.3, 17.4) 48 (46, 49) 716 21.1
West Virginia 6 *** 15.9 (14.9, 17.0) 49 (46, 50) 200 16.3
Nevada 6 *** 15.1 (14.2, 16.1) 50 (48, 50) 206 17.4
Massachusetts 3 ***
data not available
N/A
data not available
data not available
Puerto Rico 6 *** 9.1 (8.5, 9.6) N/A 198 6.5
Notes:
Created by statecancerprofiles.cancer.gov on 10/06/2022 10:34 am.

State Cancer Registries may provide more current or more local data.

Data cannot be shown for the following areas. For more information on what areas are suppressed or not available, please refer to the table.
Massachusetts, Puerto Rico

⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The 1969-2018 US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
Data not available for this combination of data selections.

Source: SEER and NPCR data. For more specific information please see the table.

Interpret Rankings provides insight into interpreting cancer incidence statistics. When the population size for a denominator is small, the rates may be unstable. A rate is unstable when a small change in the numerator (e.g., only one or two additional cases) has a dramatic effect on the calculated rate.

Data not available for this combination of geography, cancer site, age, and race/ethnicity.

Data for United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top